Nexpoint Diversified Real Estate Trust SC TO-I/A, filed Dec 16, 2020
Nexpoint Diversified Real Estate Trust (NXDT)
As filed with the Securities and Exchange Commission on December 16, 2020
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE TO
(Amendment No. 4)
Tender Offer Statement Under Section 14(d)(1) or 13(e)(1)
of the Securities Exchange Act Of 1934
NexPoint Strategic Opportunities Fund
(Name of Subject Company (Issuer))
NexPoint Strategic Opportunities Fund
(Name of Filing Person (Issuer))
Common shares of beneficial interest, par value $0.001
(Title of Class of Securities)
65340G205
(CUSIP Number of Securities)
Lauren Thedford
NexPoint Strategic Opportunities Fund
300 Crescent Court, Suite 700
Dallas, Texas 75201
Telephone: (844) 485-9167
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of the Person(s) Filing Statement)
With a Copy to:
| Thomas A. DeCapo Skadden, Arps, Slate, Meagher & Flom LLP 500 Boylston Street Boston, Massachusetts 02116 (617) 573-4800 |
R. Charles Miller K&L Gates, LLP 1601 K St NW #1 Washington, DC 20006 Telephone: (202) 778-9372 |
Calculation of Filing Fee
| Transaction Valuation | Amount of Filing Fee | |
| $150,000,000* | $16,365.00** | |
| * | Estimated for purposes of calculating the amount of the filing fee only. This amount is based on the offer to purchase for not more than $150,000,000 in aggregate purchase price of common shares of beneficial interest, par value $0.001 per share. |
| ** | Calculated at $109.10 per $1,000,000 of the Transaction Valuation, pursuant to Rule 0-11 of the Securities Exchange Act of 1934, as amended. |
| ☒ | Check the box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
| Amount previously paid: $16,365.00 | Filing party: NexPoint Strategic Opportunities Fund | |
| Form or registration No.: Schedule TO | Date filed: October 30, 2020 | |
| ☐ | Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
Check the appropriate boxes below to designate any transactions to which the statement relates:
| ☐ | Third-party tender offer subject to Rule 14d-1. |
| ☒ | Issuer tender offer subject to Rule 13e-4. |
| ☐ | Going-private transaction subject to Rule 13e-3. |
| ☐ | Amendment to Schedule 13D under Rule 13d-2. |
Check the following box if the filing is a final amendment reporting the results of the tender offer ☐
INTRODUCTORY STATEMENT
This amendment no. 4 (this “Amendment No. 4”) amends and supplements the Tender Offer Statement on Schedule TO (together with any subsequent amendments and supplements thereto, the “Schedule TO”), filed with the Securities and Exchange Commission (the “SEC”) by NexPoint Strategic Opportunities Fund, a Delaware statutory trust (together with its subsidiaries, “NHF” or the “Issuer”) on October 30, 2020, relating to the offer by NHF to exchange up to $150,000,000 in aggregate purchase price of the Issuer’s currently outstanding common shares of beneficial interest, par value $0.001 per share, for (i) shares of NexPoint Strategic Opportunities Fund’s 5.50% Series A Cumulative Preferred Shares, par value $0.001 and liquidation preference $25.00 per share (“Series A Preferred Shares”), and (ii) cash, upon the terms and subject to the conditions contained in the Offer to Exchange dated October 30, 2020, as amended by Amendment No. 1 to the Offer to Exchange, filed on November 17, 2020 (as so amended, the “Offer to Exchange”) and the related Letter of Transmittal. Capitalized terms used but not defined herein have the meanings ascribed to them in the Schedule TO, the Offer to Exchange or the Letter of Transmittal, as applicable.
This Amendment No. 4 is being filed to update Item 12 of the Schedule TO to include an amendment to the Offer to Exchange (as so amended, the “Amended Offer to Exchange”), which is attached hereto as Exhibit (a)(1)(vii).
Only those items amended are reported in this Amendment No. 4. Except as specifically provided herein, the information set forth in the Schedule TO, including all schedules and annexes thereto that were previously filed therewith, remains unchanged and is incorporated herein by reference, except that such information is hereby amended and supplemented to the extent specifically provided for herein and to the extent amended and supplemented by the exhibit filed herewith.
You should read this Amendment No. 4 together with the Schedule TO, the Amended Offer to Exchange and the Letter of Transmittal.
| ITEM 12. | EXHIBITS. |
Item 12 of the Schedule TO is hereby deleted and replaced in its entirety by the following:
| Exhibit No. |
Document | |
| (a)(1)(i) |
Offer to Exchange dated October 30, 2020. (1) | |
| (a)(1)(ii) |
Letter of Transmittal. (1) | |
| (a)(1)(iii) |
Letter to Clients for use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees. (1) | |
| (a)(1)(iv) |
Letter to Clients. (1) | |
| (a)(1)(v) |
Notice of Guaranteed Delivery. (1) | |
| (a)(1)(vi) |
Amendment No. 1 to Offer to Exchange dated October 30, 2020. (7) | |
| (a)(1)(vii) |
Amendment No. 2 to Offer to Exchange dated October 30, 2020. (9) | |
| (a)(5)(i) |
Press Release issued on October 30, 2020. (1) | |
| (a)(5)(ii) |
Press Release issued on November 10, 2020. (6) | |
| (a)(5)(iii) |
Press Release issued on December 11, 2020. (8) | |
| (b) |
Not applicable. | |
| (d)(1) |
Amended and Restated Agreement and Declaration of Trust of NexPoint Strategic Opportunities Fund. (1) | |
| (d)(2) |
Amended and Restated By-Laws of NexPoint Strategic Opportunities Fund. (1) | |
| (d)(3) |
Form of Statement of Preferences of 5.50% Series A Preferred Shares of NexPoint Strategic Opportunities Fund. (1) | |
| (d)(4) |
Dividend Reinvestment Plan. (2) | |
| (d)(5) |
Amended and Restated Investment Advisory Agreement, dated June 29, 2006, between the Company and NexPoint Advisors, L.P. (3) | |
| (d)(6) |
Administration Services Agreement, dated June 29, 2006, between the Issuer and Highland Capital Management, L.P. (4) | |
| (d)(7) |
Amendment No. 1, dated June 6, 2008, to Administration Services Agreement, dated December 4, 2006, between the Issuer and Highland Capital Management, L.P. (4) | |
| (d)(8) |
Transfer Agency and Registrar Services Agreement, dated January 18, 2013, between the Issuer and American Stock Transfer & Trust Company, LLC. (4) | |
| (d)(9) |
Master Sub-Administration Agreement, dated July 23, 2018, between SEI investments Global Funds Services and NexPoint Advisors, L.P. (2) | |
| (d)(10) |
Master Custodian Agreement dated October 3, 2018 between Bank of New York Mellon (“BNY”) and NexPoint Real Estate Strategies Fund, NexPoint Healthcare Opportunities Fund, NexPoint Latin American Opportunities Fund, NexPoint Discount Strategies Fund, NexPoint Energy and Materials Opportunities Fund, NexPoint Strategic Income Fund and NexPoint Event Driven Fund (the “Interval Funds”) listed on Annex A thereto (as Annex A may be amended from time to time). (5) | |
| (d)(11) |
Amendment 1 to Master Custodian Agreement dated April 8, 2019 between BNY and the Issuer, the Interval Funds, the series of Highland Funds II, the series of Highland Funds I, the Issuer, Highland Income Fund, Highland Global Allocation Fund and Gambier Bay, LLC. (5) | |
| (d)(12) |
Amendment 2 to Master Custodian Agreement dated April 8, 2019 between BNY and the Issuer, the Interval Funds, the series of Highland Funds II, the series of Highland Funds I, the Issuer, Highland Income Fund, Highland Global Allocation Fund and Gambier Bay, LLC. (5) | |
| (d)(13) |
Form of Amendment to the Transfer Agency and Registrar Services Agreement, dated October 30, 2020, between the Issuer and American Stock Transfer & Trust Company, LLC. (1) | |
| (g) |
Not applicable. | |
| (h) |
Not applicable. | |
| (1) | Incorporated by reference to the Issuer’s Tender Offer Statement on Schedule TO (File No. 005-83652), filed on October 30, 2020. |
| (2) | Incorporated by reference to the Issuer’s Registration Statement on Form N-2 (File No. 333-230078), filed on March 5, 2019. |
| (3) | Incorporated by reference to Post-Effective Amendment No. 2 to the Issuer’s Registration Statement on Form N-2 (File No. 333-173004), filed on August 21, 2013. |
| (4) | Incorporated by reference to Post-Effective Amendment No. 6 to the Issuer’s Registration Statement on Form N-2 (File No. 333-173004), filed on April 30, 2015. |
| (5) | Incorporated by reference to Post-Effective Amendment No. 1 to the Issuer’s Registration Statement on Form N-2 (File No. 333-230078), filed on August 27, 2019. |
| (6) | Incorporated by reference to Amendment No. 1 to the Issuer’s Tender Offer Statement on Schedule TO (File No. 005-83652), filed on November 10, 2020. |
| (7) | Incorporated by reference to Amendment No. 2 to the Issuer’s Tender Offer Statement on Schedule TO (File No. 005-83652), filed on November 17, 2020. |
| (8) | Incorporated by reference to Amendment No. 3 to the Issuer’s Tender Offer Statement on Schedule TO (File No. 005-83652), filed on December 11, 2020. |
| (9) | Filed herewith. |
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| NexPoint Strategic Opportunities Fund | ||
| By: | /s/ Lauren Thedford | |
| Name: | Lauren Thedford | |
| Title: | Secretary | |
Dated as of: December 16, 2020
Exhibit (a)(1)(vii)
AMENDMENT NO. 2
TO
OFFER TO EXCHANGE
NEXPOINT STRATEGIC OPPORTUNITIES FUND
300 Crescent Court
Suite 700
Dallas, Texas 75201
OFFER TO EXCHANGE
COMMON SHARES, PAR VALUE $0.001 PER SHARE,
FOR
5.50% SERIES A CUMULATIVE PREFERRED SHARES, PAR VALUE $0.001 AND LIQUIDATION
PREFERENCE $25.00 PER SHARE AND CASH
THIS EXCHANGE OFFER WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME,
ON JANUARY 4, 2020, UNLESS THE EXCHANGE OFFER IS EXTENDED (SUCH DATE AND
TIME, AS IT MAY BE EXTENDED, THE “EXPIRATION DATE”).
This Amendment No. 2 (this “Amendment No. 2”) amends and supplements, as set forth below, the Offer to Exchange dated October 30, 2020 (together with any amendments or supplements thereto, including this Amendment No. 2, the “Offer to Exchange”) relating to the offer by NexPoint Strategic Opportunities Fund, a Delaware statutory trust (the “Company,” “we,” “us,” or “our”), to exchange the Company’s currently outstanding common shares of beneficial interest, par value $0.001 per share (“Common Shares”), for newly-issued shares of the Company’s 5.50% Series A Cumulative Preferred Shares, par value $0.001 and liquidation preference $25.00 per share (“Series A Preferred Shares”) and cash, on the terms and subject to the conditions set forth in the Offer to Exchange and in the accompanying letter of transmittal (the “Letter of Transmittal”). All capitalized terms used but not defined in this Amendment No. 2 have the meanings ascribed to them in the Offer to Exchange.
This Amendment No. 2 should be read together with the Offer to Exchange and the Letter of Transmittal. All references to and requirements regarding the Offer to Exchange and the Letter of Transmittal shall be deemed to refer to the Offer to Exchange, as amended and supplemented by this Amendment No. 2, and the Letter of Transmittal, respectively. Except as set forth herein, all terms and conditions of the Exchange Offer remain unchanged and in full force and effect.
*****
The date of this Amendment No. 2 is December 16, 2020
The Offer to Exchange is hereby amended and supplemented as follows:
| 1. | Each reference in the Offer to Exchange to “5:00 p.m., New York City time, on December 10, 2020” as an expiration date or the “Expiration Date” is hereby amended by replacing it with “5:00 p.m., New York City time, on January 4, 2020,” unless we extend the period of time for which the Exchange Offer is open, in which case the term “Expiration Date” means the latest time and date on which the Exchange Offer, as so extended, expires. |
| 2. | Each reference to “December 15, 2020 (three business days after the expiration date)” as the “settlement date” is here hereby amended by replacing it with “January 7, 2020 (three business days after the Expiration Date),” although the date is subject to change as described in the Offer to Exchange. |
| 3. | The disclosure under the heading “2. What is the Purpose of the Exchange Offer?” beginning on page 9 is hereby deleted and replaced in it its entirety by the following: |
Shares of closed-end funds, like the Company, often trade at a discount to net asset value (“NAV”). The Board and the Investment Adviser regularly evaluate and implement potential solutions to address the Company’s trading discount to NAV, which have included:
| • | the Common Share repurchase program that had been in effect prior to the commencement of the Exchange Offer, which had provided for repurchases of up to 10% of the Common Shares over a one-year period beginning April 24, 2020; |
| • | the Conversion proposal, which was approved by shareholders at the special meeting on August 28, 2020 (the “Special Meeting”); |
| • | publishing additional commentary on the Company’s holdings in order to provide shareholders with additional information about the management of the Company and greater transparency into the portfolio and the holdings in the Company’s REIT subsidiaries; and |
| • | communicating regularly with existing and prospective shareholders. |
Although the Board and the Investment Adviser had believed that these measures would help to narrow the trading discount to NAV, the discount, while narrowing initially upon the announcement of the Conversion proposal, has instead continued to widen since the approval of the Conversion at the Special Meeting. See “Market and Net Asset Value Information.”
The purpose of the Exchange Offer is provide holders of Common Shares with an opportunity to exchange their Common Shares at a premium to the current market price, while increasing the NAV per Common Share for holders of Common Shares who choose not to participate, or not to participate fully, in the Exchange Offer. In particular, the Board and the Investment Adviser believe that the Exchange Offer:
| • | would allow a significant number of shareholders to tender their Common Shares at a premium to the current market price of up to 12.3% (based on the closing price per Common Share of $10.69 on December 14, 2020 and the maximum Purchase Price of $12.00 per Common Share); |
| • | will increase the NAV per Common Share by (i) 5.1% if $75 million in value of Common Shares is tendered and (ii) as much as 12.1% if $150 million in value of Common Shares is tendered (based on the Company’s NAV per Common Share of $17.56 on December 14, 2020, and the maximum Purchase Price of $12.00 per Common Share); and |
| • | has the potential to narrow the trading discount to NAV. |
The net income earned by the Company (and therefore allocated to the holders of Common Shares) is estimated to decrease by approximately (i) 0.27% per year, if $75 million in value of Common Shares is tendered, and (ii) 0.31% per year, if $150 million in value of Common Shares is tendered, in each case due to the additional costs of paying dividends on the Series A Preferred Shares. These decreases are equivalent to approximately (i) $0.05 per Common Share, if $75 million in value of Common Shares is tendered, and (ii) $0.07 per Common Share if $150 million in value of Common Shares is tendered. The Board and the Investment Adviser believe this reduction in income will be offset by the increase in NAV per Common Share, which as noted above is estimated to be up to (i) 5.1%, or $0.90, per Common Share, if $75 million in value of Common Shares is tendered and (ii) 12.1%, or $2.13, per Common Share, if $150 million in value of Common Shares is tendered. The foregoing estimates assume that all Common Shares are tendered at the maximum Purchase Price of $12.00 per Common Share. In addition, the Board and the Investment Adviser also believe that the leverage represented by the issuance of the Series A Preferred Shares will benefit the holders of the remaining Common Shares by, over the long term, increasing the income and/or capital appreciation attributable to the Common Shares. See “Risk Factors and Special Considerations—The Exchange Offer is expected to result in a reduction in income attributable to common shareholders.”
2
There can be no assurance that the Exchange Offer will result in a narrowing of the trading discount. In addition, the use of leverage involves risk. See “Risk Factors and Special Considerations—Leverage Risk.”
| 4. | The disclosure under the sub-heading “Reduction in Income Risk” on page 26 is hereby deleted and replaced in its entirety by the following: |
Reduction in Income Risk. The net income earned by the Company (and therefore allocated to the holders of Common Shares) is estimated to decrease by approximately (i) 0.27% per year, if $75 million in value of Common Shares is tendered, and (ii) 0.31% per year, if $150 million in value of Common Shares is tendered, in each case due to the additional costs of paying dividends on the Series A Preferred Shares. These decreases are equivalent to approximately (i) $0.05 per Common Share, if $75 million in value of Common Shares is tendered, and (ii) $0.07 per Common Share if $150 million in value of Common Shares is tendered. The Board and the Investment Adviser believe this reduction in income will be offset by the increase in NAV per Common Share, which is estimated to be up to (i) 5.1%, or $0.90, per Common Share, if $75 million in value of Common Shares is tendered and (ii) 12.1%, or $2.13, per Common Share, if $150 million in value of Common Shares is tendered. The foregoing estimates assume that all Common Shares are tendered at the maximum Purchase Price of $12.00 per Common Share. In addition, the Board and the Investment Adviser also believe that the leverage represented by the issuance of the Series A Preferred Shares will benefit the holders of the remaining Common Shares by, over the long term, increasing the income and/or capital appreciation attributable to the Common Shares.
| 5. | The disclosure under the heading “The Exchange Offer is expected to result in a reduction in income attributable to common shareholders” on page 54 is hereby deleted and replaced in its entirety by the following: |
The net income earned by the Company (and therefore allocated to the holders of Common Shares) is estimated to decrease by approximately (i) 0.27% per year, if $75 million in value of Common Shares is tendered, and (ii) 0.31% per year, if $150 million in value of Common Shares is tendered, in each case due to the additional costs of paying dividends on the Series A Preferred Shares. These decreases are equivalent to approximately (i) $0.05 per Common Share, if $75 million in value of Common Shares is tendered, and (ii) $0.07 per Common Share if $150 million in value of Common Shares is tendered. The Board and the Investment Adviser believe this reduction in income will be offset by the increase in NAV per Common Share, which is estimated to be up to (i) 5.1%, or $0.90, per Common Share, if $75 million in value of Common Shares is tendered and (ii) 12.1%, or $2.13, per Common Share, if $150 million in value of Common Shares is tendered. The foregoing estimates assume that all Common Shares are tendered at the maximum Purchase Price of $12.00 per Common Share.
| 6. | The third and fourth paragraphs under the sub-heading “We are dependent on the Investment Adviser, its affiliates and their personnel. We may be unable to find suitable replacements if our management agreement is terminated” on page 87 are hereby by deleted and replaced in their entirety by the following: |
On November 13, 2020, HCMLP filed an amended plan of reorganization and disclosure statement with the Court (the “Amended Plan”), which was subsequently accepted by the Creditors and approved by the Court. On November 30, 2020, HCMLP provided notice of termination of the Shared Services Agreement to the Investment Adviser, effective January 31, 2021. However, based upon on-going discussions with HCMLP, the Investment Adviser expects to be able to continue to receive these services through a transfer of personnel, equipment and facilities from HCMLP either to the Investment Adviser or to a third-party service provider.
| 7. | The second paragraph under the sub-heading “Substantial Conflicts of Interest” on page 88 is hereby deleted and replaced in its entirety by the following: |
On November 13, 2020, HCMLP filed an amended plan of reorganization and disclosure statement with the Court (the “Amended Plan”). On November 30, 2020, HCMLP provided notice of termination of the Shared Services Agreement to the Investment Adviser, effective January 31, 2021. However, based upon on-going discussions with HCMLP, the Investment Adviser expects to be able to continue to receive these services through a transfer of personnel, equipment and facilities from HCMLP either to the Investment Adviser or to a third-party service provider.
Future investment selection and determination may be expected to differ between HCMLP and the Investment Adviser. Employees of HCMLP providing services to the Investment Adviser could face conflicts arising from, for example, HCMLP and the Investment Adviser acting separately with respect to investment determinations on assets commonly held by clients respectively of HCMLP and the Investment Adviser, although any such persons will not have sole investment discretion with respect to any determination made by the Investment Adviser for its clients.
3